Related Experiment Video
Updated: Feb 15, 2026
06:48
Live Imaging of Chemokine Receptors in Zebrafish Neutrophils During Wound Responses
Published on: December 4, 2020
2.9K
Chemokine ligand-receptor interactions critically regulate cutaneous wound healing
Erich Bünemann1, Norman-Philipp Hoff1, Bettina Alexandra Buhren1
1Department of Dermatology, University Clinic Duesseldorf, 40225, Duesseldorf, Germany.
European Journal of Medical Research
|January 18, 2018
Summary
Chemokines are key regulators of skin wound healing. Targeting the chemokine network offers new therapeutic strategies for improving wound closure and managing healing disorders.
Area of Science:
- Cell biology
- Immunology
- Dermatology
Background:
- Wound healing involves complex cell migration.
- Chemokines (chemoattractant proteins) are crucial for directed cell movement.
- The role of chemokines in skin wound healing requires further elucidation.
Purpose of the Study:
- To comprehensively analyze the chemokine network in cutaneous wound healing.
- To understand chemokine-driven communication pathways in skin repair.
Main Methods:
- Systematic time-course analysis of mediators in a murine wound model.
- Investigated cytokines, growth factors, adhesion molecules, matrix metalloproteinases, and chemokines.
- Assessed expression and function of chemokine receptors on skin cells.
Main Results:
- Chemokines were highly regulated during wound healing, with matching receptor expression.
- Keratinocytes, fibroblasts, and endothelial cells express functional chemokine receptors.
- Chemokine ligand-receptor interactions enhanced in vitro wound repair of skin cells.
Conclusions:
- Presents a comprehensive analysis of mediators in acute cutaneous wound healing.
- Findings suggest targeting the chemokine network for therapeutic wound closure strategies.
- Highlights potential for new treatments for wound healing disorders.
Related Concept Videos
00:49Ligand Binding and Linkage
5.7K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.7K
02:40Ligand Binding Sites
15.3K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
15.3K
01:29Drug-Receptor Interactions
7.6K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.6K
01:21G-protein Coupled Receptors
132.2K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
132.2K
01:28Drug-Receptor Interaction: Antagonist
5.1K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
5.1K
01:25Drug-Receptor Interaction: Agonist
4.2K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
4.2K